Search Results - "Contel, Maria"

Refine Results
  1. 1

    Metal-based antibody drug conjugates. Potential and challenges in their application as targeted therapies in cancer by del Solar, Virginia, Contel, María

    Published in Journal of inorganic biochemistry (01-10-2019)
    “…Antibody drug conjugates have emerged as a very attractive type of targeted therapy in cancer. They combine the antigen-targeting specificity of monoclonal…”
    Get full text
    Journal Article
  2. 2

    Encapsulation of Gold-Based Anticancer Agents in Protease-Degradable Peptide Nanofilaments Enhances Their Potency by Marciano, Yaron, del Solar, Virginia, Nayeem, Nazia, Dave, Dhwanit, Son, Jiye, Contel, María, Ulijn, Rein V.

    Published in Journal of the American Chemical Society (11-01-2023)
    “…We investigated the use of amphiphilic, protease-cleavable peptides as encapsulation moieties for hydrophobic metallodrugs, in order to enhance their…”
    Get full text
    Journal Article
  3. 3

    Preclinical evaluation of an unconventional ruthenium‐gold‐based chemotherapeutic: RANCE‐1, in clear cell renal cell carcinoma by Elie, Benelita T., Hubbard, Karen, Pechenyy, Yuriy, Layek, Buddhadev, Prabha, Swayam, Contel, Maria

    Published in Cancer medicine (Malden, MA) (01-08-2019)
    “…Background There are few effective treatments for patients with advanced clear cell renal cell carcinoma (CCRCC). Recent findings indicate that ruthenium‐gold…”
    Get full text
    Journal Article
  4. 4

    Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer by Nayeem, Nazia, Contel, Maria

    Published in Chemistry : a European journal (21-06-2021)
    “…This review focuses on studies of coordination and organometallic compounds as potential chemotherapeutics against triple negative breast cancer (TNBC) which…”
    Get full text
    Journal Article
  5. 5

    Customizing Morphology, Size, and Response Kinetics of Matrix Metalloproteinase-Responsive Nanostructures by Systematic Peptide Design by Son, Jiye, Kalafatovic, Daniela, Kumar, Mohit, Yoo, Barney, Cornejo, Mike A, Contel, María, Ulijn, Rein V

    Published in ACS nano (26-02-2019)
    “…Overexpression and activation of matrix metalloproteinase-9 (MMP-9) is associated with multiple diseases and can serve as a stimulus to activate nanomaterials…”
    Get full text
    Journal Article
  6. 6

    Potential Anticancer Heterometallic Fe–Au and Fe–Pd Agents: Initial Mechanistic Insights by Lease, Nicholas, Vasilevski, Vadim, Carreira, Monica, de Almeida, Andreia, Sanaú, Mercedes, Hirva, Pipsa, Casini, Angela, Contel, María

    Published in Journal of medicinal chemistry (25-07-2013)
    “…A series of gold(III) and palladium(II) heterometallic complexes with new iminophosphorane ligands derived from ferrocenylphosphanes [{Cp-P(Ph2)N-Ph}2Fe] (1),…”
    Get full text
    Journal Article
  7. 7

    Titanocene–Gold Complexes Containing N‑Heterocyclic Carbene Ligands Inhibit Growth of Prostate, Renal, and Colon Cancers in Vitro by Mui, Yiu Fung, Fernández-Gallardo, Jacob, Elie, Benelita T, Gubran, Ahmed, Maluenda, Irene, Sanaú, Mercedes, Navarro, Oscar, Contel, Marı́a

    Published in Organometallics (09-05-2016)
    “…We report on the synthesis, characterization, and stability studies of new titanocene complexes containing a methyl group and a carboxylate ligand (mba =…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Unconventional Anticancer Metallodrugs and Strategies to Improve Their Pharmacological Profile by Contel, María

    Published in Inorganics (01-07-2019)
    “…For the past 41 years, metal-based drugs have been widely used for the treatment of cancer [...]…”
    Get full text
    Journal Article
  10. 10

    Versatile synthesis of cationic N-heterocyclic carbene-gold(i) complexes containing a second ancillary ligand. Design of heterobimetallic ruthenium-gold anticancer agents by Fernández-Gallardo, Jacob, Elie, Benelita T, Sanaú, Mercedes, Contel, María

    “…We describe a versatile and quick route to cationic gold(i) complexes containing N-heterocyclic carbenes and a second ancillary ligand (such as phosphanes,…”
    Get more information
    Journal Article
  11. 11

    Frontispiece: Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer by Nayeem, Nazia, Contel, Maria

    Published in Chemistry : a European journal (21-06-2021)
    “…Triple negative breast cancer (TNBC) has one of the poorest prognoses and worst survival rates for patients, with chemotherapy still the gold standard for…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancer by Elie, Benelita T., Fernández-Gallardo, Jacob, Curado, Natalia, Cornejo, Mike A., Ramos, Joe W., Contel, María

    Published in European journal of medicinal chemistry (01-01-2019)
    “…Following promising recent in vitro and in vivo studies of the anticancer efficacies of heterometallic titanocene–gold chemotherapeutic candidates against…”
    Get full text
    Journal Article
  14. 14

    Organometallic Titanocene–Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties by Fernández-Gallardo, Jacob, Elie, Benelita T, Sulzmaier, Florian J, Sanaú, Mercedes, Ramos, Joe W, Contel, María

    Published in Organometallics (24-11-2014)
    “…Early–late transition metal TiAu2 compounds [(η-C5H5)2Ti­{OC­(O)­CH2PPh2AuCl}2] (3) and new [(η-C5H5)2Ti­{OC­(O)-4-C6H4­PPh2AuCl}2] (5) were evaluated as…”
    Get full text
    Journal Article
  15. 15

    Organometallic Palladium Complexes with a Water-Soluble Iminophosphorane Ligand As Potential Anticancer Agents by Carreira, Monica, Calvo-Sanjuán, Rubén, Sanaú, Mercedes, Marzo, Isabel, Contel, María

    Published in Organometallics (27-08-2012)
    “…The synthesis and characterization of a new water-soluble iminophosphorane ligand TPAN-C(O)-2BrC6H4 (1, C,N-IM; TPA = 1,3,5-triaza-7-phosphaadamantane) is…”
    Get full text
    Journal Article
  16. 16

    Design, synthesis and characterisation of new chimeric ruthenium(II)-gold(I) complexes as improved cytotoxic agents by Massai, Lara, Fernández-Gallardo, Jacob, Guerri, Annalisa, Arcangeli, Annarosa, Pillozzi, Serena, Contel, María, Messori, Luigi

    “…Two heterobimetallic complexes, i.e. [RuCl2(p-cymene)(μ-dppm)AuC] (1) and [RuCl2(p-cymene)(μ-dppm)Au(S-thiazoline)] (3), based on known cytotoxic…”
    Get more information
    Journal Article
  17. 17

    A heterometallic ruthenium–gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer by Elie, Benelita T., Pechenyy, Yuriy, Uddin, Fathema, Contel, María

    Published in Journal of biological inorganic chemistry (01-05-2018)
    “…Heterobimetallic compounds are designed to harness chemotherapeutic traits of distinct metal species into a single molecule. The ruthenium–gold (Ru–Au) family…”
    Get full text
    Journal Article
  18. 18

    A Bis(ortho-amine)aryl−Gold(I) Compound as an Efficient, Nontoxic, Arylating Reagent by Contel, Maria, Stol, Marianne, Casado, Miguel A, van Klink, Gerard P. M, Ellis, Dianne D, Spek, Anthony L, van Koten, Gerard

    Published in Organometallics (14-10-2002)
    “…A novel strategy for the synthesis of bis(ortho-amine)chelated monoanionic bisaminoaryl−metal complexes is presented. This method constitutes the exchange of a…”
    Get full text
    Journal Article
  19. 19

    Heterometallic titanium-gold complexes inhibit renal cancer cells in vitro and in vivo by Fernández-Gallardo, Jacob, Elie, Benelita T, Sadhukha, Tanmoy, Prabha, Swayam, Sanaú, Mercedes, Rotenberg, Susan A, Ramos, Joe W, Contel, María

    Published in Chemical science (Cambridge) (01-09-2015)
    “…Following recent work on heterometallic titanocene-gold complexes as potential chemotherapeutics for renal cancer, we report here on the synthesis,…”
    Get full text
    Journal Article
  20. 20